Fund Holdings — MPM BioImpact LLC

Total Portfolio Value:
$666.57M
Total Bought:
$169.44M
Total Sold:
$119.15M
Net Transaction:
+$50.29M
Notable People:
Ansbert K Gadicke
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Cullinan Therapeutics, Inc.(CGEM)7,648,2687,648,2680$133.39M$128.03M19.21%-$5.35M
Insmed Incorporated(INSM)615,391615,3910$41.23M$44.92M6.74%+$3.69M
Olema Pharmaceuticals, Inc.(OLMA)2,654,8672,680,596+25,729$28.73M$32.01M4.80%+$3.28M
Avidity Biosciences Inc125,000688,975+563,975$5.11M$31.64M4.75%+$26.54M
Crinetics Pharmaceuticals Inc.557,184525,845-31,339$24.96M$26.87M4.03%+$1.91M
Edgewise Therapeutics, Inc.(EWTX)740,661917,166+176,505$13.34M$24.48M3.67%+$11.14M
Iovance Biotherapeutics, Inc.(IOVA)2,366,7142,406,714+40,000$18.98M$22.60M3.39%+$3.62M
Natera, Inc.(NTRA)174,811177,099+2,288$18.93M$22.48M3.37%+$3.55M
Rocket Pharmaceuticals, Inc.(RCKT)01,066,373+1,066,373$0$19.70M2.95%+$19.70M
Mirum Pharmaceuticals, Inc.(MIRM)492,569492,723+154$16.84M$19.22M2.88%+$2.38M
Ultragenyx Pharmaceutical Inc.(RARE)380,552329,733-50,819$15.64M$18.32M2.75%+$2.68M
iTeos Therapeutics, Inc.1,745,9431,745,9430$25.91M$17.83M2.67%-$8.08M
MoonLake ImmunotherapeuticsCL A(MLTX)343,235349,063+5,828$15.09M$17.60M2.64%+$2.51M
Lantheus Holdings, Inc.(LNTH)150,000150,182+182$12.04M$16.48M2.47%+$4.44M
Madrigal Pharmaceuticals, Inc.(MDGL)71,18572,395+1,210$19.94M$15.36M2.30%-$4.58M
Disc Medicine, Inc.(IRON)305,658311,761+6,103$13.78M$15.32M2.30%+$1.54M
Relay Therapeutics, Inc.(RLAY)1,274,4592,033,041+758,582$8.31M$14.39M2.16%+$6.08M
Twist Bioscience Corporation(TWST)0294,930+294,930$0$13.32M2.00%+$13.32M
Revolution Medicines, Inc.(RVMD)289,396291,391+1,995$11.23M$13.21M1.98%+$1.98M
Guardant Health, Inc.(GH)500,000499,170-830$14.44M$11.45M1.72%-$2.99M
Akero Therapeutics Inc385,990392,544+6,554$9.06M$11.26M1.69%+$2.21M
Kalvista Pharmaceuticals Inc881,937896,915+14,978$10.39M$10.39M1.56%-$2.9K
Compass Therapeutics, Inc.(CMPX)5,005,0865,641,894+636,808$5.01M$10.38M1.56%+$5.38M
Cartesian Therapeutics, Inc.(RNAC)259,696629,423+369,727$7.01M$10.15M1.52%+$3.13M
Sutro Biopharma, Inc.(STRO)3,043,3462,832,064-211,282$8.92M$9.80M1.47%+$881.9K
Aquestive Therapeutics Inc01,796,750+1,796,750$0$8.95M1.34%+$8.95M
Janux Therapeutics, Inc.(JANX)0171,105+171,105$0$7.77M1.17%+$7.77M
Viking Therapeutics, Inc.(VKTX)118,960120,982+2,022$6.31M$7.66M1.15%+$1.35M
Xenon Pharmaceuticals Inc.(XENE)0165,800+165,800$0$6.53M0.98%+$6.53M
Stoke Therapeutics, Inc.(STOK)0479,452+479,452$0$5.89M0.88%+$5.89M
Repare Therapeutics, Inc.1,639,8491,639,8490$5.41M$5.64M0.85%+$229.6K
Intellia Therapeutics, Inc.(NTLA)443,503267,557-175,946$9.93M$5.50M0.82%-$4.43M
Zentalis Pharmaceuticals, Inc.(ZNTL)1,450,0001,465,801+15,801$5.93M$5.39M0.81%-$536.4K
Trevi Therapeutics, Inc.(TRVI)1,510,1741,538,517+28,343$4.50M$5.14M0.77%+$638.3K
Wave Life Sciences, Inc.(WVE)0624,471+624,471$0$5.12M0.77%+$5.12M
Arcturus Therapeutics Holdings Inc.(ARCT)0219,508+219,508$0$5.09M0.76%+$5.09M
Werewolf Therapeutics, Inc.(HOWL)2,388,0112,388,0110$5.83M$5.06M0.76%-$764.2K
Adaptimmune Therapeutics plcADR(ADAPY)5,095,9125,095,9120$4.97M$4.84M0.73%-$127.4K
ALX Oncology Holdings Inc.(ALXO)2,180,8642,409,862+228,998$13.15M$4.39M0.66%-$8.76M
PTC Therapeutics, Inc.(PTCT)089,715+89,715$0$3.33M0.50%+$3.33M
89Bio Inc1,121,736330,000-791,736$8.99M$2.44M0.37%-$6.54M
REGENXBIO Inc.(RGNX)557,07650,000-507,076$6.52M$524.5K0.08%-$5.99M
Solid Biosciences Inc011,518+11,518$0$80.3K0.01%+$80.3K
Alkermes plc(ALKS)557,5560-557,556$13.44M$0—-$13.44M
Allakos344,9000-344,900$344.9K$0—-$344.9K
Avadel Pharmaceuticals PLCADR783,2420-783,242$11.01M$0—-$11.01M
Axsome Therapeutics, Inc.(AXSM)132,3120-132,312$10.65M$0—-$10.65M
Fulcrum Therapeutics, Inc.(FULC)1,444,8510-1,444,851$8.96M$0—-$8.96M
Hillevax Inc645,0850-645,085$9.33M$0—-$9.33M
Immatics N.V.(IMTX)417,8100-417,810$4.85M$0—-$4.85M
Morphic Holding Inc369,3840-369,384$12.58M$0—-$12.58M
Scholar Rock Holding Corporation(SRRK)1,028,3300-1,028,330$8.57M$0—-$8.57M
Verve Therapeutics, Inc638,1630-638,163$3.11M$0—-$3.11M
Xeris Biopharma Holdings Inc4,830,5260-4,830,526$10.87M$0—-$10.87M
Page 1 of 1
MPM BioImpact LLC — 13F Holdings — Q3 2024 | TickerTrail